These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 33078555)
1. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction. Iasella CJ; Hoji A; Popescu I; Wei J; Snyder ME; Zhang Y; Xu W; Iouchmanov V; Koshy R; Brown M; Fung M; Langelier C; Lendermon EA; Dugger D; Shah R; Lee J; Johnson B; Golden J; Leard LE; Ellen Kleinhenz M; Kilaru S; Hays SR; Singer JP; Sanchez PG; Morrell MR; Pilewski JM; Greenland JR; Chen K; McDyer JF Am J Transplant; 2021 Jun; 21(6):2145-2160. PubMed ID: 33078555 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction. Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446 [TBL] [Abstract][Full Text] [Related]
3. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction. Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A; Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503 [TBL] [Abstract][Full Text] [Related]
4. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts. Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A; Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation. Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386 [TBL] [Abstract][Full Text] [Related]
6. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients. Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659 [TBL] [Abstract][Full Text] [Related]
7. When tissue is the issue: A histological review of chronic lung allograft dysfunction. Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874 [TBL] [Abstract][Full Text] [Related]
8. Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature. Dugger DT; Fung M; Hays SR; Singer JP; Kleinhenz ME; Leard LE; Golden JA; Shah RJ; Lee JS; Deiter F; Greenland NY; Jones KD; Langelier CR; Greenland JR Am J Transplant; 2021 Jan; 21(1):362-371. PubMed ID: 32885581 [TBL] [Abstract][Full Text] [Related]
9. The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction. Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Saggar R; Huynh RH; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA Am J Transplant; 2018 Jan; 18(1):136-144. PubMed ID: 28637080 [TBL] [Abstract][Full Text] [Related]
10. Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation. Renaud-Picard B; Berra G; Hwang D; Huszti E; Miyamoto E; Berry GJ; Pal P; Juvet S; Keshavjee S; Martinu T J Heart Lung Transplant; 2024 Oct; 43(10):1701-1715. PubMed ID: 38663465 [TBL] [Abstract][Full Text] [Related]
11. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction. Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576 [TBL] [Abstract][Full Text] [Related]
12. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841 [TBL] [Abstract][Full Text] [Related]
13. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome. Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544 [TBL] [Abstract][Full Text] [Related]
14. Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation. Itabashi Y; Ravichandran R; Bansal S; Bharat A; Hachem R; Bremner R; Smith M; Mohanakumar T Transplantation; 2021 Jun; 105(6):1337-1346. PubMed ID: 32890135 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of gene expression profiling of bronchoalveolar lavage cells in acute lung allograft rejection. Weigt SS; Wang X; Palchevskiy V; Li X; Patel N; Ross DJ; Reynolds J; Shah PD; Danziger-Isakov LA; Sweet SC; Singer LG; Budev M; Palmer S; Belperio JA J Heart Lung Transplant; 2019 Aug; 38(8):845-855. PubMed ID: 31122726 [TBL] [Abstract][Full Text] [Related]
16. Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation. Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Huynh RH; Saggar R; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA Am J Transplant; 2017 May; 17(5):1294-1303. PubMed ID: 27676455 [TBL] [Abstract][Full Text] [Related]
17. Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction. Shino MY; Todd JL; Neely ML; Kirchner J; Frankel CW; Snyder LD; Pavlisko EN; Fishbein GA; Schaenman JM; Mason K; Kesler K; Martinu T; Singer LG; Tsuang W; Budev M; Shah PD; Reynolds JM; Williams N; Robien MA; Palmer SM; Weigt SS; Belperio JA Am J Transplant; 2022 Sep; 22(9):2169-2179. PubMed ID: 35634722 [TBL] [Abstract][Full Text] [Related]
18. JAK-STAT activation contributes to cytotoxic T cell-mediated basal cell death in human chronic lung allograft dysfunction. Khatri A; Todd JL; Kelly FL; Nagler A; Ji Z; Jain V; Gregory SG; Weinhold KJ; Palmer SM JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36946463 [TBL] [Abstract][Full Text] [Related]
19. A novel model for dissecting roles of IL-17 in lung transplantation. Chen R; Liang F; Chen Q; Xu J; Ding Y J Thorac Dis; 2018 Jun; 10(6):3298-3307. PubMed ID: 30069326 [TBL] [Abstract][Full Text] [Related]
20. Detection of chronic lung allograft dysfunction using ventilation-weighted Fourier decomposition MRI. Voskrebenzev A; Greer M; Gutberlet M; Schönfeld C; Renne J; Hinrichs J; Kaireit T; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J Am J Transplant; 2018 Aug; 18(8):2050-2060. PubMed ID: 29607606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]